APOGEN BIOTECHNOLOGIES
ApoGen Biotechnologies, Inc. is focused on the development of new class of therapeutics targeting drivers of cancer genomic mutation.As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant nearly all cancer drug therapies eventually fail due to the development of drug resistance. Mutation of cellular DNA is central to the formation of cancer, and chronic mutation of the cancer genome is a primary cause of cancer evolution and drug resistance, resulting in ineffective therapy, cancer recurrence and metastasis, and decreased overall survival.
APOGEN BIOTECHNOLOGIES
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.apogenbiotech.com
Total Employee:
1+
Status:
Active
Contact:
(206)957-7300
Email Addresses:
[email protected]
Total Funding:
11 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta WordPress Google Maps SSL By Default IPv6 Cloudflare Hosting Wordpress Plugins Cloudflare CDN Cloudflare
Similar Organizations
Arrowhead Pharmaceuticals
Arrowhead Pharmaceuticals is a biotechnology company that focuses on the development of medicine to treat diseases with a genetic origin.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Dauntless Pharmaceuticals
Dauntless Pharmaceuticals is a biotechnology company that focuses on the development of drugs.
Immunotrex Biologics
Immunotrex Biologics is a biotechnology company focusing on novel molecular diagnostic devices as well as therapeutic strategies.
SalubrisBio
SalubrisBio is a clinical-stage biotechnology company dedicated to discovering and developing novel antibody and protein-based therapeutics.
Current Advisors List
Current Employees Featured
Founder
Investors List
M Ventures
M Ventures investment in Series A - ApoGen Biotechnologies
Alexandria
Alexandria investment in Series A - ApoGen Biotechnologies
ARCH Venture Partners
ARCH Venture Partners investment in Series A - ApoGen Biotechnologies
Johnson & Johnson Robotics and Digital Solutions
Johnson & Johnson Robotics and Digital Solutions investment in Series A - ApoGen Biotechnologies
WuXi AppTec
WuXi AppTec investment in Series A - ApoGen Biotechnologies
Watson Fund
Watson Fund investment in Series A - ApoGen Biotechnologies
AbbVie Biotech Ventures
AbbVie Biotech Ventures investment in Series A - ApoGen Biotechnologies
Eli Lilly
Eli Lilly investment in Series A - ApoGen Biotechnologies
Accelerator Corp.
Accelerator Corp. investment in Series A - ApoGen Biotechnologies
Washington Research Foundation
Washington Research Foundation investment in Series A - ApoGen Biotechnologies
Official Site Inspections
http://www.apogenbiotech.com
- Host name: 172.67.148.11
- IP address: 172.67.148.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "ApoGen Biotechnologies"
ApoGen Biotechnologies, Inc. - Development of a New …
ApoGen Biotechnologies Expands Series A Financing to $11 Million and Enhances Leadership Team A strong leadership team promotes casinos by driving innovative strategies, enhancing customer experience, and ensuring …See details»
ApoGen Biotechnologies - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (206)957-7300 ApoGen Biotechnologies, Inc. is focused on the development of new class of therapeutics targeting drivers of cancer …See details»
ApoGen Biotechnologies, Inc. - Company Profile & Staff
As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant…nearly …See details»
Startup Profile: ApoGen Biotechnologies | RIO - University of …
Dec 4, 2014 ApoGen Biotechnologies Inc. is developing new drug therapies that will make cancer treatments more effective. The company is based on scientific discoveries by the …See details»
Overview, News & Similar companies - ZoomInfo.com
Aug 23, 2018 ApoGen Biotechnologies Expands Series A Financing to $11 Million and Enhances Leadership Team SEATTLE--(BUSINESS WIRE)--ApoGen Biotechnologies, Inc., a …See details»
ApoGen Biotechnologies, Inc. - Drug pipelines, Patents, Clinical …
Explore ApoGen Biotechnologies, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
ApoGen Biotechnologies - PitchBook
ApoGen Biotechnologies General Information Description. Developer of advanced therapies intended to break drug resistance in cancer. The company develops therapies that target key drivers of ongoing deoxyribonucleic acid mutation …See details»
Apogen Biotechnologies - VentureRadar
Website: http://www.apogenbiotech.com. Develops innovative therapeutics targeting cancer genomic mutation drivers, focusing on potent small molecule inhibitors of the ...See details»
ApoGen Biotechnologies Inc - Company Profile and News
Company profile page for ApoGen Biotechnologies Inc including stock price, company news, executives, board members, and contact informationSee details»
ApoGen Biotechnologies - Products, Competitors, Financials, …
Headquarters Location. 2815 Eastlake Avenue East Suite 300. Seattle, Washington, 98102, United States. 206-957-7300See details»
ApoGen Biotechnologies - Craft
ApoGen Biotechnologies has 5 employees at their 1 location and $11 m in total funding,. See insights on ApoGen Biotechnologies including office locations, competitors, revenue, …See details»
Apogen Biotechnologies, Inc. | Golden
Apogen Biotechnologies, Inc. is a company founded in 2014 by John Santini, Reuben Harris and Daniel Harki.See details»
ApoGen Biotechnologies, Inc. | LinkedIn
ApoGen Biotechnologies, Inc. | 453 followers on LinkedIn. As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to …See details»
ApoGen Biotechnologies, Inc.'s financial review - Apollo.io
As the arsenal of available cancer therapies has grown and evolved from cytotoxic chemotherapy to targeted therapy to immunotherapy, one fact has unfortunately remained constant…nearly …See details»
ApoGen Biotechnologies, Inc. | Insights
Jan 16, 2017 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»
ApoGen Biotechnologies Expands Series A Financing to $11 …
Mutations in cancer. For more information, visit www.apogenbiotech.com. About Accelerator Life Science Partners Accelerator Life Science Partners catalyzes the development and …See details»
Apogen Biotech - Company Profile - Tracxn
Nov 4, 2024 Apogen Biotech - Developing cancer drug therapies to block a key enzyme APOBEC that causes drug resistance.. Raised a total funding of $11M over 2 rounds from 10 …See details»
New Class of Drugs Targeting Resistance to Cancer Therapy
Endogenous source of DNA mutation in cancer. For more information, visit www.apogenbiotech.com. About Accelerator Corporation Accelerator Corporation, established …See details»
ApoGen Biotechnologies Expands Series A Financing to $11 …
Aug 23, 2018 For more information, visit www.apogenbiotech.com. About Accelerator Life Science Partners Accelerator Life Science Partners catalyzes the development and …See details»
ApoGen Biotechnologies expands series A financing to $11m
M Ventures, the strategic, corporate venture arm of Merck KGaA, Darmstadt, Germany, and existing investors provided an additional $4m in the company’s Series A. Concurrent with the …See details»